Cell-based therapy for prevention and reversal of myocardial remodeling - Wikidata - wikimedia - TriplyDB

Cell-based therapy for prevention and reversal of myocardial remodeling

Cell-based therapy for prevention and reversal of myocardial remodeling

http://www.wikidata.org/entity/Q36176132

about

Stem cell therapy for CHD: towards translation Cardiac stem cells: biology and clinical applications Therapeutic potential of Pnmt+ primer cells for neuro/myocardial regeneration Use of mesenchymal stem cells for therapy of cardiac disease The pathobiology of acute coronary syndromes: clinical implications and central role of the mitochondria Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis.SCF increases cardiac stem cell migration through PI3K/AKT and MMP‑2/‑9 signaling Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of microposts Clinical research skills development program in cell-based regenerative medicine.Ultrasound-mediated microbubble destruction enhances the therapeutic effect of intracoronary transplantation of bone marrow stem cells on myocardial infarction.Contemporary perspective on endogenous myocardial regeneration.Cardiac Regeneration and Stem Cells.S-Nitrosoglutathione Reductase Deficiency Enhances the Proliferative Expansion of Adult Heart Progenitors and Myocytes Post Myocardial Infarction Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy Characterization and analysis of long non-coding rna (lncRNA) in In Vitro- and Ex Vivo-derived cardiac progenitor cells.Cardiac stem cell niche, MMP9, and culture and differentiation of embryonic stem cells Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial c-kit+ Cardiac Stem Cells: Spontaneous Creation or a Perplexing Reality Right and left ventricular diastolic pressure-volume relations: a comprehensive review The advancing field of cell-based therapy: insights and lessons from clinical trials.Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.Key developments in stem cell therapy in cardiology.Molecular targets of current and prospective heart failure therapies.Focus on cardiac pericytes.Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal S β-Catenin stabilization promotes proliferation and increase in cardiomyocyte number in chick embryonic epicardial explant culture.Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.Stimulatory Effects of Mesenchymal Stem Cells on cKit+ Cardiac Stem Cells Are Mediated by SDF1/CXCR4 and SCF/cKit Signaling Pathways.Real-Time Force and Frequency Analysis of Engineered Human Heart Tissue Derived from Induced Pluripotent Stem Cells Using Magnetic Sensing.Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential.Allogeneic cell therapy: a new paradigm in therapeutics.Cell Therapy: Targeting Endogenous Repair Versus Remuscularization Update on innovative initiatives for the American Journal of Physiology-Heart and Circulatory Physiology.The proper delivery pressure for cardioplegic solution in neonatal cardiac surgery - an investigation of biomechanical and structural properties of neonatal and adult coronary arteries.Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine.Cardiomyogenesis of periodontal ligament-derived stem cells by dynamic tensile strain.Mesenchymal Stem Cells in Cardiology.Mesenchymal stem cells preserve neonatal right ventricular function in a porcine model of pressure overload.New insights into cell-based therapy for heart failure from the CHART-1 study.

P2860

Q26786034-B75050FF-A47E-4D54-BBCD-96BB06778D1A Q26825051-D25C65CD-8681-4845-87A4-6C36A487FCB4 Q27002374-61ED7881-71CB-4128-BAE3-8EC5FD1B8EEF Q27003127-6FB5B4C4-F872-4160-90C2-669304F7AF7F Q27026299-201E976C-E97C-4B3C-B0F5-A7948BEF4722 Q33710719-7B244F0F-C00A-4F71-9765-1EB3456D2936 Q33811230-5D2EB0B5-837B-423C-B2B7-DCF451C824E8 Q33950809-07AACE93-BA65-450F-999C-3D5FC1317E59 Q34153953-D495F360-2F1F-4206-8646-249A69F2DB92 Q35001367-AF4CE68A-C79F-4F7E-BD39-687DED54F8B8 Q35405864-961536C8-A242-432C-8C04-89D8B981F0CD Q35774278-A0750023-F6D2-41C6-AB19-EBA32B6C6C2A Q36146340-27CA5942-9B94-4DF6-97EE-613DE3DADE1D Q36168777-8068B0E6-EF21-494A-A52C-E701C550783C Q36236436-E3B4A626-76F8-4CF1-AA5B-0BD426FACCE5 Q36412564-6A9D6BA2-0A11-41B3-81C9-98A3B2FF2796 Q36420341-D5A9D8C1-FA55-4303-8BF8-3654E16485AF Q36603453-2160B7D2-8B2B-4B39-AF4C-71B9AB495A8B Q36657000-51E3FDA0-0AFE-496B-A6CF-C69398A90F1C Q36675269-6D3F3178-33F8-4382-982F-B5029A98BD27 Q37328786-0F26941A-D5F6-4A7A-9ABD-21C660671623 Q38073092-1FB48365-BC70-46DE-8E12-C2C7BCC7F06E Q38076435-62F6BFE3-4DA7-4AFF-9B31-C6681DBB93D1 Q38076688-2D42137F-626F-46E0-8FB6-4A3C9DA86E99 Q38084912-A9237D3B-539A-4B92-AA8F-E280BC69096E Q38435541-3611A80C-EF7C-4EB2-B5AB-E458BD141A4E Q38607511-916D9344-96B3-4080-8DF5-9BCC555A9972 Q38874116-7561D2D7-1D73-4AC8-8DD2-8D1215343EE0 Q39534918-27DE8EAC-A44D-4B90-9856-B1BEA132E04C Q41573786-E60D43A0-D31E-45C3-854B-D6ADA20A9E35 Q41976922-C7EA7F0D-71C9-4137-ADDD-4F378BA9A05D Q42545530-C41EFCEC-8066-479A-84A3-24B3F7BE8639 Q42675929-65BA9EE8-9451-41FB-92CC-88D6D132BCAD Q44132620-E61E5BDE-5CA4-477A-9F21-BCEEFDF58D5D Q45951596-2B14AAEA-2116-401C-9F90-03CB75C54D92 Q46130031-4E6F9616-6869-4FA2-A619-B1674A79DC5F Q46477394-6DA51934-9EC9-4172-AA4A-B275017887C4 Q47146529-B533D30E-FE9C-437B-B3AC-787D622F7450 Q48800221-3D9BDB86-C1B5-4239-A238-EA9621936C7E Q49833988-EDC41EF8-E8B6-41BB-992F-1B5A29120B64

P2860

Cell-based therapy for prevention and reversal of myocardial remodeling

http://www.wikidata.org/entity/Q36176132

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Cell-based therapy for prevention and reversal of myocardial remodeling

@ast

Cell-based therapy for prevention and reversal of myocardial remodeling

@en

type

label

Cell-based therapy for prevention and reversal of myocardial remodeling

@ast

Cell-based therapy for prevention and reversal of myocardial remodeling

@en

prefLabel

Cell-based therapy for prevention and reversal of myocardial remodeling

@ast

Cell-based therapy for prevention and reversal of myocardial remodeling

@en

P1433

Q36176132-F65726A4-360A-41C7-81B6-B76BE48088DB

P1476

Q36176132-ED8EE85C-B37C-422A-8771-FD8FC0D84E9A

P2093

Q36176132-1A509596-8ABA-45C8-8AE8-D4C63D2C4C9F

Q36176132-2409D808-2D75-4680-87DE-9CC4FA1A3D39

Q36176132-74091110-C01D-430F-8F2B-2DD2D45FD9F0

Q36176132-AECBFDE0-EA60-414F-AD83-00FED9E1B6EE

Q36176132-D96614C2-014B-4DF3-9FAB-02D6F99057B0

P2860

Q36176132-02431320-F634-4812-87E3-98F88C47F65A

Q36176132-02E6FD23-2A7C-4591-902A-6E8AF3586294

Q36176132-04070333-956E-45B9-9D57-F239C95CC32C

Q36176132-08268738-E60A-429E-BAFD-CC752FC60C08

Q36176132-086ED45B-22AA-4DE9-BCE9-3AB503F77117

Q36176132-09CD3D6D-2195-4EE2-B4B7-764658F11E2D

Q36176132-0A267BC7-FA69-482D-874A-468AFA5864E9

Q36176132-0A3508EB-F537-48D6-9942-CD99DE4FD9A5

Q36176132-0ADE1A57-D28C-4836-806C-4EE8D7D73690

Q36176132-0D824137-9393-412B-A55B-C365D8F99643

P304

Q36176132-66052094-699B-46FE-8CA1-4236F789956D

P31

Q36176132-DFD49D06-42AA-4922-B8D2-48E61AC90B3D

P356

Q36176132-7854BAB6-192C-401B-8BD4-69722BBC004A

P433

Q36176132-DBAC9A23-8BF1-422D-935F-FA999D90FC5F

P478

Q36176132-933C804E-3036-4015-AA24-FE1600DF9821

P577

Q36176132-8AAFD672-4410-4FB6-99D7-4C1DE4E2F6DA

P5875

Q36176132-E8B20410-323E-4263-8A03-0C06C21C7952

P698

Q36176132-D0D70ED0-9262-4AED-BBC8-2F32E89D0BA1

P932

Q36176132-BB8EF3BA-E084-47FC-ABC5-5331AF262F1E

P356

AJPHEART.00221.2012

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Cell-based therapy for prevention and reversal of myocardial remodeling

@en

P2093

Ivonne H Schulman

http://www.w3.org/2001/XMLSchema#string

Joshua M Hare

http://www.w3.org/2001/XMLSchema#string

Konstantinos E Hatzistergos

http://www.w3.org/2001/XMLSchema#string

Vasileios Karantalis

http://www.w3.org/2001/XMLSchema#string

Wayne Balkan

http://www.w3.org/2001/XMLSchema#string

P2860

Mesenchymal stem cells avoid allogeneic rejection

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells

Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase

Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells

The stem cell niche in regenerative medicine

Biomaterials to enhance stem cell function in the heart

Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology

Multilineage potential of adult human mesenchymal stem cells

MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1

P304

H256-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00221.2012

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

303

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225065002

http://www.w3.org/2001/XMLSchema#string

P698

22636682

http://www.w3.org/2001/XMLSchema#string

P932

3423164

http://www.w3.org/2001/XMLSchema#string